A multi-center, randomized, double-blind, placebo-controlled, dose-ranging study of Colal-Pred in the treatment of patients with moderate to severe ulcerative colitis

Trial Profile

A multi-center, randomized, double-blind, placebo-controlled, dose-ranging study of Colal-Pred in the treatment of patients with moderate to severe ulcerative colitis

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Sep 2010

At a glance

  • Drugs Prednisolone metasulfobenzoate sodium (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jan 2010 Actual patient number (190) added as reported by ClinicalTrials.gov.
    • 22 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top